(Q34894851)

https://api.crossref.org/works/10.1128/AAC.5.1.75

5 August 2017

title

Clinical Study of the Use of the New Aminoglycoside Tobramycin for Therapy of Infections Due to Gram-Negative Bacteria (English)

1 reference

https://api.crossref.org/works/10.1128/AAC.5.1.75

10 February 2023

main subject

Gram-negative bacteria

0 references

1 reference

10 February 2023

author name string

G. Jaffe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4599125

10 February 2023

W. Ravreby

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4599125

10 February 2023

B. R. Meyers

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4599125

10 February 2023

S. Z. Hirschman

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4599125

10 February 2023

language of work or name

English

0 references

publication date

1 January 1974

1 reference

full work available at URL

5 August 2017

https://europepmc.org/articles/PMC428921

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4599125

https://europepmc.org/articles/PMC428921?pdf=render

10 February 2023

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4599125

https://journals.asm.org/doi/pdf/10.1128/AAC.5.1.75

10 February 2023

1 reference

https://api.crossref.org/works/10.1128/AAC.5.1.75

Antimicrobial Agents and Chemotherapy

10 February 2023

published in

1 reference

5 August 2017

volume

5

1 reference

5 August 2017

issue

1

1 reference

5 August 2017

page(s)

75-81

1 reference

Factors Affecting Mortality of Gram-Negative Rod Bacteremia

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

Tobramycin: in vitro activity and comparison with kanamycin and gentamicin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

Is there complete cross-resistance of gram-negative bacilli to gentamicin and tobramycin?

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

In Vitro Studies of Tobramycin, an Aminoglycoside Antibiotic

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

Tobramycin: In Vitro Antibacterial Spectrum of a New Aminoglycoside

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

Pharmacologic Studies on Tobramycin and Comparison with Gentamicin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

Gram-negative rod bacteremia.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

Pharmacokinetics of the aminoglycoside antibiotic tobramycin in humans

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

Pharmacokinetic studies of tobramycin and gentamicin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

RESPIRATORY AND CARDIAC ARREST AFTER INTRAVENOUS ADMINISTRATION OF KANAMYCIN WITH REVERSAL OF TOXIC EFFECTS BY NEOSTIGMINE.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

Gram-negative rod bacteremia. An analysis of 100 patients

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

Clinical Experience with Gentamicin in Japan

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=428921

Gram-negative septicemia: a growing threat

26 October 2018

1 reference

12 December 2020

The importance of underlying disease in patients with gram-negative bacteremia

1 reference

12 December 2020

Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentration

1 reference

12 December 2020

Pharmacology of Gentamicin in Man

1 reference

12 December 2020

Clinical Significance of Rising Incidence of Infections Due to Gram-Negative Bacilli

1 reference

12 December 2020

Occurrence of serious bacterial infections since introduction of antibacterial agents

1 reference

12 December 2020

Identifiers

DOI

10.1128/AAC.5.1.75

1 reference

5 August 2017

1 reference

5 August 2017

1 reference